top of page
Blog
Search


New Evidence: The WID-easy Test Can Reduce NHS Costs
Snowsill et al.; Cost-minimisation analysis of the WID-qEC epigenetic biomarker compared to transvaginal ultrasound for triaging abnormal uterine bleeding. Value in Health, 2026 A newly peer-reviewed cost-minimisation analysis published in Value in Health demonstrates that WID-easy offers a compelling economic and clinical alternative to transvaginal ultrasound (TVUS) as the first-line triage test for patients presenting with abnormal uterine bleeding (AUB) referred to the Ur
2 min read


Prostin Supply Disruption: How UK Maternity Units Are Adapting IOL Pathways
The ongoing Prostin supply disruption is beginning to place significant pressure on induction of labour (IOL) services across the UK. As maternity teams work to maintain safe, effective care, many are reviewing and adapting their existing cervical ripening pathways. The current disruption impacts several commonly used prostaglandin options: Prostin® E2 3 mg vaginal tablets (pessary) Prostin® E2 1 mg/2.5 ml gel Prostin® E2 2 mg/2.5 ml gel How Maternity Units Are Responding to
2 min read


DILAPAN‑S vs. Balloon Catheter - Which is Best for Labour Induction?
Labour induction is a common and critical aspect of obstetric care, and choosing the right cervical ripening method can influence both maternal comfort and clinical workflow. Recent clinical evidence from 6 studies involving over 1,700 patients comparing DILAPAN‑S , a synthetic osmotic dilator, with the Balloon catheter offers insights into the benefits and drawbacks of each method. Mechanical Methods in Labour Induction There are two primary mechanical approaches to cervica
2 min read


DILAPAN-S® Digital Insertion: Tips, Technique and Guidance for Midwives
Digital insertion of DILAPAN-S is a natural extension of existing clinical skills- and with practice, can become a confident and effective technique in induction of labour (IOL).
2 min read


AGHeadlines: Clinical Updates and NHS Developments in Women’s Health – Winter 2025/26
Welcome to the latest edition of AGHeadlines, providing you with insight every quarter on the latest technologies and tools in women's health helping clinicians deliver exceptional care for women in the UK. In This Edition WEQAS launches a dedicated External Quality Assessment scheme for AmniSure® NHS pilot sites expand for the WID-easy® endometrial cancer test Upcoming conferences and clinical training webinars Limited-time offers across obstetric and neonatal products WEQAS
2 min read


Addressing Medical Misogyny in Gynaecology: The role of the WID-easy Test
BMJ Feature: Medical misogyny and “harrowing” experiences: what are doctors doing to improve outpatient gynaecological procedures? Adele Waters, BMJ 2025 Outpatient gynaecological procedures, particularly hysteroscopy and endometrial biopsy, remain central to the investigation of abnormal uterine bleeding (AUB) and suspected endometrial cancer. However, a recent BMJ feature brings attention to an issue many clinicians recognise, but services have historically struggled to ad
2 min read
Gynaecology medical devices UK
bottom of page
